Carcinoid Tumors
November 2019 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Metastatic Bilateral Strumal Carcinoid: A Case Report and Review of the Literature.
Authors:Borghese M, Razzore P, Ferrero A, Daniele L, Mariani LL, Sgro LG, DE Rosa G, Biglia N
Institution:Academic Department of Gynecology and Obstetrics, University of Turin, Mauriziano Hospital, Turin, Italy martina.borghese1989@gmail.com. Hospital, Turin, Italy. Hospital, Turin, Italy. Hospital, Turin, Italy. Hospital, Turin, Italy.
Journal:Anticancer Res. 2019 Sep;39(9):5053-5056. doi: 10.21873/anticanres.13697.

2:Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung.
Authors:Altinay S, Metovic J, Massa F, Gatti G, Cassoni P, Scagliotti GV, Volante M, Papotti M
Institution:Division of Pathology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.; Pathology Division of the Department of Oncology, University of Turin, San Luigi Hospital, Regione Gonzole 10, Orbassano, 10043, Torino, Italy. marco.volante@unito.it.; Pathology Division of the Department of Medical Sciences, University of Turin, Turin, Italy.
Journal:Virchows Arch. 2019 Sep;475(3):325-334. doi: 10.1007/s00428-019-02596-8. Epub 2019 Jun 15.

3:Multimodal treatment of thymic carcinoid: a case report.
Authors:Cahajlova R, Cerna M, Kinova S
Journal:Vnitr Lek. 2019 Spring;65(5):363-368.

4:Role of Serial 68Ga DOTANOC PET-CT Scans in Follow-up of Metastatic Bronchial Carcinoid: 12 Year Follow-up From a Tertiary Care Institute.
Authors:Tripathy S, Kumar R
Institution:From the Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Journal:Clin Nucl Med. 2019 Jul;44(7):602-603. doi: 10.1097/RLU.0000000000002593.

5:Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review.
Authors:Wolin EM, Benson Iii AB
Institution:Montefiore Einstein Center for Cancer Care, Bronx, New York, USA, edward.wolin@mssm.edu. Illinois, USA.
Journal:Oncology. 2019;96(6):273-289. doi: 10.1159/000499049. Epub 2019 Apr 24.

6:Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis.
Authors:Joish VN, Shah S, Tierce JC, Patel D, McKee C, Lapuerta P, Zacks J
Institution:Lexicon Pharmaceuticals, Inc., The Woodlands, TX 77381, USA. Sinai Health System, New York, NY 10029, USA.
Journal:Future Oncol. 2019 Apr;15(12):1397-1406. doi: 10.2217/fon-2018-0960. Epub 2019 Feb 8.

7:Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012-2017.
Authors:Abou Saleh M, Mansoor E, Anindo M, Isenberg G
Institution:Digestive Disease Institute, Cleveland Clinic Foundation, 2049 E 100th St, A Building, Cleveland, OH, 44195, USA. University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Wearn 244, Cleveland, OH, 44106, USA. 39401, USA. University Hospitals Cleveland Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Wearn 244, Cleveland, OH, 44106, USA. Gerard.Isenberg@UHhospitals.org.
Journal:Dig Dis Sci. 2019 May;64(5):1328-1334. doi: 10.1007/s10620-018-5402-z. Epub 2018 Dec 5.

8:More than meets the MRI: case report of a carcinoid tumour metastasis mimicking a meningioma.
Authors:Harrison CJ, Martin SC, Hofer M, Corkill R, Jeyaretna DS, Griffiths SJ
Institution:a University of Oxford Medical Sciences Office , Oxford , UK.
Journal:Br J Neurosurg. 2019 Apr;33(2):229-230. doi: 10.1080/02688697.2017.1327018. Epub 2017 May 11.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: July 3, 2019
174 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT83536718

Coupon Expires: January 12, 2020



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2019 Medifocus, Inc. All rights reserved.